During 2021, a moderate growth of 14% was observed, reaching $339 million of purchases in Central America from Mexico, where the main importer in the region was Guatemala with $83 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
By 2021, there will be a reduction in the import of pharmaceutical products containing insulin at the Central American level by 44%, equivalent to $1,948 million, with Costa Rica being the main buyer with $10 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
More than 10 thousand results were observed during May 2022 in tenders under the heading "health and medicines", ranging from medical treatments to equipment and machinery used in the health sector.
An analysis by CentralAmericaData's Business Intelligence department shows interesting data on the processes that during May 2022 were published with contracts to provide pharmaceuticals, equipment and medical supplies to the several Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
A cut-off for the first quarter of the year shows a relevant figure in the health and medicine sector for the Central American region and the Dominican Republic.
An analysis of CentralAmericaData's Business Intelligence department shows interesting data on the processes that in the first quarter of 2022 were published with contracts to supply pharmaceuticals, equipment and medical supplies to the various Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
Pharmaceutical companies need to apply location intelligence techniques and foot traffic analytics to identify consumer mobility patterns, in order to maximize sales and generate more efficient expansion models.
The correlation between foot traffic, sales, and the success of pharmacy franchises have been studied and proven, so the development of this type of analysis has become a priority in the site selection process and expansion modeling.
For the second quarter of 2021, the purchase of pharmaceutical products in the region was dominated by Costa Rica with $428 million, the largest supplier to the region was Germany with $167 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
Mobility analytics and location intelligence play an important role in business by helping to understand the behavioral patterns of consumers in any given zone of interest or point of sale.
Pedestrian flow analysis, location intelligence and point-of-interest categorization have revolutionized the way retail and wholesale industries implement expansion, commercial and operational strategies in the pharmaceutical sector.
Between the first three months of 2020 and 2021, the imported value of pharmaceutical products in Central America registered a positive variation, going from $825 million to $866 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"].
BID Invest granted Calox de Costa Rica S.A. a loan that will help the company invest in substantial improvements in its production capacity and seek international certifications to validate the quality of its products.
The project has two main objectives. The first is to acquire the existing plant to make improvements in infrastructure and energy efficiency in order to become certified and expand its production capacity in the medium term.
During 2020, Central America's imports of pharmaceutical products containing insulin totaled $35 million, and purchases from Danish companies increased 11% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
During 2020, companies in the region allocated $134 million for the import of vaccines for human use, and purchases from Russian companies increased 54% over what was reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The National Oncology Institute of Panama tenders the supply of 9,738 units of the drug bevacizumab 25mg/ml, concentrate for vial solution.
Panama Government Purchase 2021-0-12-11-08-08-LV-018486:
"The contract shall have a thirteen (13) month term effective from the notification of the contract or purchase order or from the publication of the order to proceed through the electronic portal 'PanamaCompra'.
During 2020, Central American imports of pharmaceutical products totaled $3.502 billion, and purchases from Mexican companies increased by 2% over the amount reported in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graph"]
The Ministry of Public Finances published the bases for four public tenders, through which the supply of pharmaceutical products to be used by the Ministry of Public Health will be contracted.
The four tenders are in the Open Contract Purchase modality for the supply and acquisition by the State of Medicinal and Pharmaceutical Products.
español
8280
